studied human medicine at the Medical University of Innsbruck and clinical trial management at the Beuth University of Applied Sciences in Berlin. Since 2020 she has been a consultant in the Value & Access Strategy department at the IGES Institute. In addition to medical writing, her main areas of work include issues relating to study planning and benefit assessment of innovative medicines using real world evidence.